- Uber Technologies Inc (NYSE: UBER) announced it has partnered with NimbleRx for delivering prescriptions to patients in the Dallas and Seattle area markets
Uber Technologies Inc (NYSE: UBER) announced it has partnered with NimbleRx for delivering prescriptions to patients in the Dallas and Seattle area markets. This partnership is critical for Uber as the company’s core ride-hailing service has taken a hit due to the COVID-19 pandemic.
In March 2018, Uber established Uber Health to help medical businesses with transportation. And Uber has been collaborating a number of healthcare partners since then along with building a HIPAA-secure platform.
“Now more than ever, it is critical that people get their medications safely and efficiently, and over the last several months we have seen a significant increase in demand for prescription delivery from both consumers and retail pharmacies,” said Nimble founder and CEO Talha Sattar. “Through this partnership with Uber Health, we are able to dramatically increase the availability of on-demand delivery of an essential product like prescriptions, which is leading to a further increase in demand in all markets we are already active in.”
Uber’s partnership with NimbleRx competes against delivery services offered by CVS Health and Walgreens Boots Alliance. Both of those pharmacy chains are now offering their own prescription home-delivery services. And Amazon offers an online pharmacy that packages medication and delivers it to your door every month through its acquisition of PillPack.
“By tapping into Uber’s delivery expertise, Uber Health is able to facilitate prescription delivery directly to people’s homes. Uber Health began with a vision to help alleviate transportation as a barrier to care, and helping our most vulnerable populations get the prescriptions they need to stay healthy is a natural and exciting next step for us,” added Dan R. Trigub, Head of Uber Health.
